NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $1.97 -0.11 (-5.29%) (As of 11/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About IM Cannabis Stock (NASDAQ:IMCC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IM Cannabis alerts:Sign Up Key Stats Today's Range$1.93▼$2.1650-Day Range$1.97▼$2.9652-Week Range$1.13▼$8.10Volume27,932 shsAverage Volume98,046 shsMarket Capitalization$4.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More… 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here IM Cannabis Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks8th Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for IM Cannabis.Read more about IM Cannabis' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for IM Cannabis are expected to grow in the coming year, from ($5.61) to ($2.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIM Cannabis has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about IM Cannabis' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.26% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.26% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month News and Social Media0.6 / 5News SentimentN/A Search InterestOnly 1 people have searched for IMCC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.91% of the stock of IM Cannabis is held by insiders.Percentage Held by InstitutionsOnly 7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address IMCC Stock News HeadlinesIM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by ManagementOctober 4, 2024 | prnewswire.comIMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2October 2, 2024 | prnewswire.comBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…November 2, 2024 | Crypto 101 Media (Ad)IM 29 would legalize recreational marijuana in SDSeptember 17, 2024 | msn.comIM Cannabis Corp.: IM Cannabis Announces Appointment of Shmulik Arbel to Board of DirectorsSeptember 11, 2024 | finanznachrichten.deIM Cannabis Announces Appointment of Shmulik Arbel to Board of DirectorsSeptember 11, 2024 | prnewswire.comIM Cannabis Corp. (IMCC)August 25, 2024 | finance.yahoo.comIM Cannabis Corp. (IMCC) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $2.1420 at the beginning of 2024. Since then, IMCC shares have decreased by 8.0% and is now trading at $1.97. View the best growth stocks for 2024 here. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) issued its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.84) by $0.67. The company earned $10.78 million during the quarter, compared to the consensus estimate of $9.62 million. IM Cannabis had a negative net margin of 26.46% and a negative trailing twelve-month return on equity of 97.26%. When did IM Cannabis' stock split? IM Cannabis's stock reverse split before market open on Friday, July 12th 2024. The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), General Electric (GE) and AppLovin (APP). Company Calendar Last Earnings8/14/2024Today11/02/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:IMCC CUSIPN/A CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees340Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.8293) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,040,000.00 Net Margins-26.46% Pretax Margin-29.61% Return on Equity-97.26% Return on Assets-25.27% Debt Debt-to-Equity Ratio0.07 Current Ratio0.69 Quick Ratio0.52 Sales & Book Value Annual Sales$36.15 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$4.55 per share Price / Book0.43Miscellaneous Outstanding Shares2,230,000Free Float2,100,000Market Cap$4.39 million OptionableNot Optionable Beta0.44 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:IMCC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.